Skip to content

Dose-response relationships of LSD-induced subjective experiences in humans.

Tim Hirschfeld, Johanna Prugger, Tomislav Majić, Timo T Schmidt

Neuropsychopharmacology October 1, 2023 DOI: 10.1038/s41386-023-01588-2 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review and meta-analysis Peer reviewed
Intervention LSD
Dose up to 200 μg base
Topics LSD
Keywords Psychedelics Consciousness research Pharmacology
Citations 24
Key findings Most scales of altered states of consciousness show a sigmoid-like increase with LSD dose, plateauing at around 100 μg, with the strongest modulation in perception and illusory imagination.

Abstract

Lysergic acid diethylamide (LSD) is a potent classic serotonergic psychedelic, which facilitates a variety of altered states of consciousness. Here we present the first meta-analysis establishing dose-response relationship estimates of the altered states of consciousness induced by LSD. Data extracted from articles identified by a systematic literature review following PRISMA guidelines were obtained from the Altered States Database. The psychometric data comprised ratings of subjective effects from standardized and validated questionnaires: the Altered States of Consciousness Rating Scale (5D-ASC, 11-ASC) and the Mystical Experience Questionnaire (MEQ30). We performed meta-regression analyses using restricted cubic splines for data from studies with LSD doses of up to 200 μg base. Most scales revealed a sigmoid-like increase of effects, with a plateauing at around 100 μg. The most strongly modulated factors referred to changes in perception and illusory imagination, followed by positively experienced ego-dissolution, while only small effects were found for Anxiety and Dread of Ego Dissolution. The considerable variability observed in most factors and scales points to the role of non-pharmacological factors in shaping subjective experiences. The established dose-response relationships may be used as general references for future experimental and clinical research on LSD to compare observed with expected subjective effects and to elucidate phenomenological differences between psychedelics.

Comparable studies

Other systematic reviews and meta-analyses on LSD, most cited first.

Study Year Design Participants
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Participants in randomized controlled trials of LSD for alcoholism 2012 Meta-analysis n = 536
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review
Default Mode Network Modulation by Psychedelics: A Systematic Review Participants from included studies 2022 Systematic review
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews Patients with mood, anxiety, or substance-use disorders, including cancer patients and... 2018 Systematic review of systematic reviews
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials Patients with psychiatric disorders, primarily alcoholism 2020 Systematic review n = 567

Citations in the library

Cited by 24

and 19 more in the library

Cites 53

and 48 more in the library

Explore topics